Folate Analog [EPC]

Folate Analog [EPC] was reported 49763 times

Drugs of the Folate Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MUSCLE CRAMP 52 0.0293
1 HAEMORRHAGIC ANAEMIA 99 0.0225
2 NEPHROGENIC ANAEMIA 95 0.0205
3 BLOOD TESTOSTERONE DECREASED 117 0.0171
4 HYPERPARATHYROIDISM SECONDARY 42 0.0167
5 INJECTION SITE PAPULE 67 0.0146
6 REBOUND ACID HYPERSECRETION 41 0.0135
7 LOWER GASTROINTESTINAL HAEMORRHAGE 93 0.0126
8 PRE-EXISTING CONDITION IMPROVED 77 0.0123
9 SPINAL COLUMN STENOSIS 56 0.0118
10 WOUND COMPLICATION 40 0.0116
11 BODY HEIGHT DECREASED 123 0.0115
12 VITAMIN D DECREASED 96 0.0112
13 DIFFICULTY IN WALKING 37 0.0107
14 THROMBOPHLEBITIS SUPERFICIAL 32 0.0106
15 ENDOMETRIOSIS 49 0.0103
16 WEIGHT BEARING DIFFICULTY 26 0.0097
17 TENDON PAIN 72 0.0095
18 THERAPY CESSATION 479 0.0093
19 INITIAL INSOMNIA 94 0.0092
20 PRODUCT SUBSTITUTION ISSUE 523 0.0091
21 INTENTIONAL DEVICE MISUSE 40 0.0091
22 PHARYNGOLARYNGEAL PAIN 47 0.0088
23 WALKING AID USER 58 0.0088
24 BLOOD CALCIUM INCREASED 77 0.0088
25 FAECAL INCONTINENCE 42 0.0087
26 ACNE CYSTIC 26 0.0086
27 HANGOVER 30 0.0085
28 MUSCLE FATIGUE 36 0.0085
29 MENISCUS INJURY 52 0.0084
30 SINUS HEADACHE 50 0.0084
31 LOCAL SWELLING 145 0.0083
32 ABDOMINAL ADHESIONS 26 0.0082
33 LACERATION 77 0.0082
34 PELVIC PAIN 148 0.0081
35 DYSMENORRHOEA 107 0.0081
36 INCREASED TENDENCY TO BRUISE 74 0.0080
37 PLASMA CELL MYELOMA RECURRENT 26 0.0080
38 PROTEIN TOTAL DECREASED 30 0.0080
39 STOMACH DISCOMFORT 41 0.0079
40 PROSTATOMEGALY 31 0.0079
41 FULL BLOOD COUNT DECREASED 158 0.0078
42 SINUS CONGESTION 105 0.0078
43 MIDDLE INSOMNIA 145 0.0078
44 MENORRHAGIA 152 0.0077
45 SMALL INTESTINAL OBSTRUCTION 95 0.0077
46 SNORING 29 0.0077
47 SKIN TIGHTNESS 36 0.0076
48 INJECTION SITE NODULE 84 0.0076
49 PARANASAL SINUS HYPERSECRETION 29 0.0076
50 EXOSTOSIS 69 0.0075
51 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 41 0.0075
52 DECREASED INTEREST 44 0.0075
53 PARANASAL SINUS DISCOMFORT 28 0.0074
54 PERONEAL NERVE PALSY 42 0.0074
55 ATELECTASIS 71 0.0073
56 THERAPY CHANGE 72 0.0073
57 SPINAL OSTEOARTHRITIS 64 0.0073
58 AMMONIA INCREASED 37 0.0072
59 END STAGE RENAL DISEASE 131 0.0072
60 CHOLECYSTITIS CHRONIC 48 0.0072
61 ANORECTAL DISCOMFORT 38 0.0071
62 CAROTID ARTERY OCCLUSION 26 0.0071
63 TENDERNESS 74 0.0071
64 BALANCE DISORDER 610 0.0071
65 UPPER-AIRWAY COUGH SYNDROME 58 0.0070
66 IMPAIRED DRIVING ABILITY 80 0.0070
67 INCREASED UPPER AIRWAY SECRETION 36 0.0070
68 HOSPICE CARE 69 0.0070
69 SKIN ABRASION 33 0.0070
70 PRODUCT FORMULATION ISSUE 46 0.0070
71 HAEMATOCRIT DECREASED 138 0.0070
72 SENSATION OF HEAVINESS 27 0.0070
73 VAGINAL DISCHARGE 70 0.0069
74 MICTURITION URGENCY 79 0.0069
75 INTERNATIONAL NORMALISED RATIO DECREASED 28 0.0069
76 BREAST TENDERNESS 52 0.0069
77 COAGULOPATHY 115 0.0069
78 MUSCULOSKELETAL PAIN 360 0.0069
79 ACTIVITIES OF DAILY LIVING IMPAIRED 136 0.0069
80 GINGIVAL SWELLING 30 0.0068
81 VITAMIN D DEFICIENCY 66 0.0068
82 MENSTRUAL DISORDER 56 0.0068
83 BLOOD MAGNESIUM DECREASED 58 0.0067
84 ROSACEA 31 0.0066
85 TENDONITIS 103 0.0066
86 URINE ODOUR ABNORMAL 39 0.0066
87 ROTATOR CUFF SYNDROME 85 0.0066
88 ENERGY INCREASED 39 0.0066
89 RESTLESS LEGS SYNDROME 120 0.0066
90 INTERVERTEBRAL DISC DEGENERATION 61 0.0066
91 NERVE INJURY 73 0.0066
92 BLOOD POTASSIUM DECREASED 197 0.0065
93 SKIN WARM 38 0.0065
94 FEELING JITTERY 124 0.0065
95 METRORRHAGIA 110 0.0064
96 RASH PAPULAR 144 0.0064
97 MUSCLE TIGHTNESS 104 0.0064
98 SCAB 73 0.0064
99 FLUID OVERLOAD 93 0.0064
100 BLOOD THYROID STIMULATING HORMONE DECREASED 29 0.0064
101 ONYCHOMYCOSIS 28 0.0064
102 PANIC REACTION 46 0.0064
103 TRIGGER FINGER 26 0.0064
104 MUSCLE SPASTICITY 78 0.0063
105 FLATULENCE 360 0.0063
106 LIGAMENT RUPTURE 28 0.0063
107 BLOOD IRON DECREASED 75 0.0063
108 TEMPERATURE INTOLERANCE 65 0.0063
109 SQUAMOUS CELL CARCINOMA OF SKIN 38 0.0063
110 UTERINE LEIOMYOMA 46 0.0063
111 VAGINAL HAEMORRHAGE 273 0.0063
112 INJECTION SITE HAEMORRHAGE 501 0.0063
113 SOMNAMBULISM 41 0.0062
114 PRURITUS GENERALISED 135 0.0062
115 PROCTALGIA 40 0.0062
116 HUMERUS FRACTURE 30 0.0062
117 CHAPPED LIPS 27 0.0062
118 HAND FRACTURE 44 0.0062
119 TRICUSPID VALVE INCOMPETENCE 49 0.0062
120 HYPERKERATOSIS 34 0.0062
121 COMPRESSION FRACTURE 33 0.0062
122 MUSCLE STRAIN 53 0.0061
123 SCREAMING 39 0.0061
124 BUNDLE BRANCH BLOCK RIGHT 28 0.0061
125 HYPERAESTHESIA 50 0.0061
126 GALLBLADDER DISORDER 108 0.0060
127 SPINAL COMPRESSION FRACTURE 50 0.0060
128 SLEEP APNOEA SYNDROME 115 0.0060
129 INJECTION SITE BRUISING 480 0.0060
130 SINUSITIS 616 0.0060
131 CLOSTRIDIUM DIFFICILE INFECTION 131 0.0060
132 MENSTRUATION DELAYED 65 0.0060
133 TENDON RUPTURE 74 0.0060
134 DRY MOUTH 485 0.0060
135 CLOSTRIDIUM DIFFICILE COLITIS 63 0.0059
136 ARTHROPOD BITE 44 0.0059
137 MOOD SWINGS 189 0.0059
138 MUSCLE ATROPHY 75 0.0059
139 ABDOMINAL HERNIA 27 0.0059
140 HYPOAESTHESIA ORAL 89 0.0059
141 VULVOVAGINAL DISCOMFORT 26 0.0059
142 VENTRICULAR EXTRASYSTOLES 61 0.0059
143 POOR QUALITY DRUG ADMINISTERED 38 0.0059
144 MULTIPLE ALLERGIES 46 0.0059
145 PHOTOPSIA 37 0.0058
146 DEFAECATION URGENCY 41 0.0058
147 WHEELCHAIR USER 26 0.0058
148 BLOOD URINE PRESENT 111 0.0058
149 WRIST FRACTURE 70 0.0058
150 HOT FLUSH 440 0.0058
151 CORONARY ARTERY OCCLUSION 80 0.0058
152 BREAST PAIN 62 0.0058
153 BLOOD COUNT ABNORMAL 88 0.0058
154 IRON DEFICIENCY 26 0.0058
155 SINUS DISORDER 114 0.0058
156 BRUXISM 31 0.0057
157 HAEMORRHOIDAL HAEMORRHAGE 28 0.0057
158 OSTEOPENIA 87 0.0057
159 THERAPEUTIC RESPONSE UNEXPECTED 257 0.0057
160 CARDIAC FLUTTER 37 0.0057
161 MACULAR DEGENERATION 68 0.0057
162 POLLAKIURIA 236 0.0057
163 UPPER GASTROINTESTINAL HAEMORRHAGE 95 0.0056
164 ABASIA 139 0.0056
165 PANIC ATTACK 205 0.0056
166 FAILURE TO THRIVE 29 0.0056
167 CHRONIC KIDNEY DISEASE 424 0.0056
168 VISUAL DISTURBANCE 32 0.0056
169 PAROSMIA 42 0.0056
170 GAIT DISTURBANCE 1065 0.0056
171 EXERCISE TOLERANCE DECREASED 32 0.0056
172 BLOOD ALBUMIN DECREASED 44 0.0055
173 BONE DISORDER 101 0.0055
174 NERVE COMPRESSION 51 0.0055
175 FREQUENT BOWEL MOVEMENTS 149 0.0055
176 SEASONAL ALLERGY 78 0.0055
177 DRY THROAT 56 0.0055
178 MUSCLE SPASMS 1010 0.0055
179 GASTROOESOPHAGEAL REFLUX DISEASE 443 0.0055
180 APPLICATION SITE BURN 27 0.0055
181 DEEP VEIN THROMBOSIS 356 0.0055
182 DIZZINESS POSTURAL 53 0.0055
183 TINNITUS 251 0.0055
184 NIGHT SWEATS 176 0.0055
185 PERIPHERAL COLDNESS 75 0.0055
186 TOOTH INFECTION 72 0.0055
187 HYPERSOMNIA 156 0.0054
188 MUSCULAR WEAKNESS 618 0.0054
189 NOCTURIA 66 0.0054
190 FLUSHING 552 0.0054
191 ERUCTATION 105 0.0054
192 NASAL DISCOMFORT 43 0.0054
193 DYSGEUSIA 402 0.0054
194 HYPOPHAGIA 138 0.0054
195 SKIN ATROPHY 31 0.0054
196 FEELING DRUNK 40 0.0054
197 URINE OUTPUT DECREASED 47 0.0054
198 INSOMNIA 1429 0.0054
199 LIGAMENT SPRAIN 53 0.0054
200 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 380 0.0053
201 BLADDER DISORDER 53 0.0053
202 AGEUSIA 133 0.0053
203 PAIN IN JAW 151 0.0053
204 SCOLIOSIS 33 0.0053
205 GASTROENTERITIS VIRAL 96 0.0053
206 CHROMATURIA 120 0.0053
207 GASTROINTESTINAL HAEMORRHAGE 444 0.0053
208 PAIN OF SKIN 143 0.0053
209 DRUG EFFECT DECREASED 286 0.0053
210 CONTUSION 511 0.0053
211 TOOTH ABSCESS 54 0.0053
212 INJECTION SITE PRURITUS 355 0.0053
213 JOINT STIFFNESS 139 0.0053
214 CELLULITIS 267 0.0053
215 NECK PAIN 296 0.0053
216 LOW DENSITY LIPOPROTEIN INCREASED 41 0.0053
217 VITREOUS FLOATERS 52 0.0053
218 PRODUCT DOSE OMISSION 344 0.0053
219 FEELING HOT 323 0.0053
220 PELVIC FRACTURE 41 0.0053
221 ATRIAL FLUTTER 42 0.0053
222 RASH PRURITIC 285 0.0053
223 NAIL DISORDER 46 0.0053
224 FALL 1749 0.0052
225 RASH GENERALISED 136 0.0052
226 HIATUS HERNIA 68 0.0052
227 PERIPHERAL VASCULAR DISORDER 27 0.0052
228 GROIN PAIN 46 0.0052
229 BENIGN PROSTATIC HYPERPLASIA 27 0.0052
230 RESPIRATORY TRACT CONGESTION 83 0.0052
231 BOWEL MOVEMENT IRREGULARITY 40 0.0052
232 HEART RATE IRREGULAR 118 0.0052
233 LABORATORY TEST ABNORMAL 154 0.0052
234 RECTAL HAEMORRHAGE 224 0.0052
235 CARPAL TUNNEL SYNDROME 73 0.0052
236 DIVERTICULUM 37 0.0052
237 ACUTE RESPIRATORY FAILURE 100 0.0052
238 CHEILITIS 28 0.0052
239 DISTURBANCE IN ATTENTION 279 0.0052
240 CRYING 188 0.0052
241 TOOTH FRACTURE 57 0.0052
242 PARAESTHESIA 813 0.0052
243 EAR DISCOMFORT 53 0.0052
244 BACK INJURY 56 0.0051
245 ACNE 390 0.0051
246 SCAR 88 0.0051
247 TOOTHACHE 93 0.0051
248 HYPOVOLAEMIA 30 0.0051
249 INTERNATIONAL NORMALISED RATIO INCREASED 146 0.0051
250 BRONCHITIS 379 0.0051
251 DRUG DOSE OMISSION 846 0.0051
252 RIB FRACTURE 105 0.0051
253 HIP FRACTURE 164 0.0051
254 INJECTION SITE INDURATION 66 0.0051
255 TOOTH DISORDER 113 0.0051
256 RED BLOOD CELL COUNT DECREASED 145 0.0051
257 DYSPNOEA EXERTIONAL 191 0.0051
258 FEELING ABNORMAL 1215 0.0051
259 DYSSTASIA 148 0.0051
260 BREAST MASS 34 0.0051
261 TRANSFUSION 53 0.0051
262 HYPOAESTHESIA 757 0.0051
263 NASAL CONGESTION 297 0.0050
264 ANOREXIA 65 0.0050
265 MUSCULOSKELETAL CHEST PAIN 78 0.0050
266 RENAL CYST 40 0.0050
267 GINGIVAL PAIN 40 0.0050
268 INJECTION SITE ERYTHEMA 623 0.0050
269 ABDOMINAL DISTENSION 522 0.0050
270 ABNORMAL DREAMS 138 0.0050
271 MUSCLE TWITCHING 115 0.0050
272 UNEVALUABLE EVENT 377 0.0050
273 FISTULA 56 0.0050
274 INJECTION SITE WARMTH 102 0.0050
275 WRONG TECHNIQUE IN DRUG USAGE PROCESS 180 0.0049
276 TIC 27 0.0049
277 NASAL DRYNESS 31 0.0049
278 PULMONARY HYPERTENSION 103 0.0049
279 DYSPHONIA 289 0.0049
280 MENTAL STATUS CHANGES 137 0.0049
281 VIRAL INFECTION 164 0.0049
282 DIARRHOEA HAEMORRHAGIC 46 0.0049
283 ASTHENIA 1849 0.0049
284 JOINT INJURY 105 0.0049
285 DEPRESSION 1117 0.0049
286 DIVERTICULITIS 136 0.0049
287 GLUCOSE TOLERANCE IMPAIRED 29 0.0049
288 HICCUPS 40 0.0049
289 OROPHARYNGEAL PAIN 451 0.0049
290 BASAL CELL CARCINOMA 76 0.0049
291 MOUTH SWELLING 28 0.0048
292 INTERVERTEBRAL DISC PROTRUSION 106 0.0048
293 DEHYDRATION 646 0.0048
294 FAECES DISCOLOURED 105 0.0048
295 ABNORMAL LOSS OF WEIGHT 33 0.0048
296 DYSURIA 178 0.0048
297 RASH MACULAR 169 0.0048
298 INCONTINENCE 51 0.0048
299 BACK PAIN 1120 0.0048
300 OSTEOPOROSIS 198 0.0048
301 FEELING COLD 134 0.0048
302 CONSTIPATION 1048 0.0048
303 BLOOD CHOLESTEROL INCREASED 224 0.0048
304 NEUROPATHY PERIPHERAL 457 0.0048
305 SLUGGISHNESS 49 0.0048
306 FURUNCLE 38 0.0048
307 INFLUENZA LIKE ILLNESS 394 0.0048
308 DECUBITUS ULCER 39 0.0048
309 UPPER RESPIRATORY TRACT INFECTION 221 0.0048
310 BLOOD THYROID STIMULATING HORMONE INCREASED 44 0.0048
311 INJECTION SITE PAIN 1463 0.0048
312 IRON DEFICIENCY ANAEMIA 44 0.0048
313 NERVOUSNESS 249 0.0048
314 LARGE INTESTINE POLYP 33 0.0048
315 HEAD DISCOMFORT 84 0.0047
316 FATIGUE 3691 0.0047
317 MYALGIA 805 0.0047
318 POLYP 31 0.0047
319 EAR PAIN 92 0.0047
320 PHOTOPHOBIA 89 0.0047
321 TROPONIN INCREASED 36 0.0047
322 URINARY INCONTINENCE 140 0.0047
323 BURNING SENSATION 331 0.0047
324 RHINORRHOEA 305 0.0047
325 BLOOD CALCIUM DECREASED 53 0.0047
326 DRUG EFFECT INCOMPLETE 171 0.0047
327 DYSPEPSIA 463 0.0047
328 CHILLS 551 0.0047
329 BLOOD TRIGLYCERIDES INCREASED 83 0.0047
330 PRESYNCOPE 114 0.0047
331 ANAL FISTULA 25 0.0047
332 PROTHROMBIN TIME PROLONGED 28 0.0047
333 LETHARGY 269 0.0047
334 HYDRONEPHROSIS 35 0.0047
335 SQUAMOUS CELL CARCINOMA 44 0.0047
336 ANGER 158 0.0047
337 BLOOD SODIUM DECREASED 88 0.0047
338 STAPHYLOCOCCAL INFECTION 154 0.0047
339 MUSCULOSKELETAL DISCOMFORT 80 0.0046
340 PALPITATIONS 544 0.0046
341 ORAL PAIN 104 0.0046
342 PARAESTHESIA ORAL 67 0.0046
343 RESPIRATION ABNORMAL 32 0.0046
344 FOOT FRACTURE 88 0.0046
345 HAIR TEXTURE ABNORMAL 62 0.0046
346 LYMPHOEDEMA 32 0.0046
347 INJECTION SITE VESICLES 28 0.0046
348 DIZZINESS 2307 0.0046
349 POST-TRAUMATIC STRESS DISORDER 31 0.0046
350 CYSTITIS 147 0.0046
351 BURSITIS 56 0.0046
352 PHARYNGEAL OEDEMA 71 0.0046
353 MUSCULOSKELETAL STIFFNESS 403 0.0046
354 POOR QUALITY SLEEP 99 0.0046
355 FORMICATION 32 0.0046
356 COLD SWEAT 81 0.0046
357 CYST 57 0.0046
358 WEIGHT DECREASED 1282 0.0046
359 FLANK PAIN 43 0.0046
360 IMPAIRED WORK ABILITY 98 0.0046
361 THROAT IRRITATION 205 0.0046
362 NEURALGIA 111 0.0046
363 RENAL FAILURE CHRONIC 35 0.0045
364 BACK DISORDER 74 0.0045
365 EAR INFECTION 121 0.0045
366 OEDEMA PERIPHERAL 553 0.0045
367 ENTERITIS 29 0.0045
368 HAEMOGLOBIN DECREASED 465 0.0045
369 CONCUSSION 35 0.0045
370 ABNORMAL FAECES 37 0.0045
371 MOTOR DYSFUNCTION 46 0.0045
372 APHONIA 63 0.0045
373 CHOLELITHIASIS 148 0.0045
374 DELUSION 70 0.0045
375 ONYCHOCLASIS 31 0.0045
376 RENAL TUBULAR NECROSIS 44 0.0045
377 INJECTION SITE URTICARIA 110 0.0045
378 FLUID RETENTION 228 0.0045
379 PHOTOSENSITIVITY REACTION 74 0.0045
380 URINARY TRACT INFECTION 764 0.0045
381 GASTROINTESTINAL INFLAMMATION 35 0.0045
382 ARTHRITIS 351 0.0045
383 INJECTION SITE EXTRAVASATION 55 0.0045
384 ANKLE FRACTURE 69 0.0045
385 RETCHING 95 0.0045
386 GASTROINTESTINAL PAIN 49 0.0044
387 TENDON DISORDER 29 0.0044
388 MUSCLE DISORDER 36 0.0044
389 ABDOMINAL PAIN 1032 0.0044
390 ATRIAL FIBRILLATION 432 0.0044
391 OSTEOARTHRITIS 188 0.0044
392 RIGHT VENTRICULAR FAILURE 31 0.0044
393 MENTAL IMPAIRMENT 107 0.0044
394 PAIN IN EXTREMITY 1300 0.0044
395 HYPOKINESIA 64 0.0044
396 PLASMA CELL MYELOMA 172 0.0044
397 DYSGRAPHIA 29 0.0044
398 SKIN BURNING SENSATION 315 0.0044
399 APATHY 64 0.0044
400 RENAL FAILURE ACUTE 186 0.0044
401 CATARACT OPERATION 26 0.0044
402 DIARRHOEA 2823 0.0044
403 HYPERCALCAEMIA 54 0.0044
404 HYPOXIA 154 0.0044
405 PIGMENTATION DISORDER 27 0.0044
406 SNEEZING 98 0.0044
407 THERMAL BURN 31 0.0044
408 SKIN INFECTION 49 0.0044
409 THIRST 78 0.0044
410 MOOD ALTERED 119 0.0044
411 TREMOR 724 0.0044
412 CARDIAC PACEMAKER INSERTION 26 0.0044
413 PARANOIA 75 0.0043
414 PHARYNGITIS STREPTOCOCCAL 47 0.0043
415 DENTAL CARIES 48 0.0043
416 MEMORY IMPAIRMENT 596 0.0043
417 AORTIC ANEURYSM 33 0.0043
418 BEDRIDDEN 57 0.0043
419 LOSS OF LIBIDO 39 0.0043
420 HEARING IMPAIRED 26 0.0043
421 LIMB DISCOMFORT 134 0.0043
422 HEAD INJURY 137 0.0043
423 ANXIETY 1232 0.0043
424 SCIATICA 69 0.0043
425 INJECTION SITE MASS 160 0.0043
426 PULMONARY CONGESTION 57 0.0043
427 ORAL DISCOMFORT 60 0.0043
428 APPLICATION SITE PAIN 95 0.0043
429 DRY SKIN 575 0.0043
430 INCORRECT DRUG ADMINISTRATION DURATION 121 0.0043
431 SENSORY DISTURBANCE 69 0.0043
432 SUNBURN 32 0.0043
433 HEART RATE INCREASED 425 0.0043
434 CHOLECYSTECTOMY 49 0.0043
435 BONE PAIN 251 0.0043
436 TONGUE DISORDER 31 0.0043
437 PULMONARY EMBOLISM 407 0.0043
438 SKIN IRRITATION 196 0.0043
439 EPISTAXIS 320 0.0043
440 TRANSIENT ISCHAEMIC ATTACK 144 0.0043
441 DRUG ADMINISTERED AT INAPPROPRIATE SITE 45 0.0043
442 GASTRIC ULCER 81 0.0043
443 MOBILITY DECREASED 306 0.0043
444 PERIPHERAL SWELLING 656 0.0043
445 MIGRAINE 406 0.0042
446 EYE INFECTION 48 0.0042
447 SKIN EXFOLIATION 358 0.0042
448 PLEURAL EFFUSION 258 0.0042
449 FEAR 114 0.0042
450 NIGHTMARE 146 0.0042
451 UPPER LIMB FRACTURE 84 0.0042
452 NODULE 55 0.0042
453 CHEST PAIN 779 0.0042
454 EYE SWELLING 156 0.0042
455 CHEST DISCOMFORT 429 0.0042
456 ARTHRALGIA 1741 0.0042
457 HYPERLIPIDAEMIA 50 0.0042
458 SUPRAVENTRICULAR TACHYCARDIA 40 0.0042
459 ORAL CANDIDIASIS 55 0.0042
460 WHITE BLOOD CELL COUNT DECREASED 452 0.0042
461 DECREASED APPETITE 968 0.0042
462 DISORIENTATION 165 0.0042
463 COORDINATION ABNORMAL 58 0.0042
464 HEADACHE 2606 0.0042
465 SKIN DISCOLOURATION 191 0.0042
466 MITRAL VALVE INCOMPETENCE 47 0.0041
467 SWELLING FACE 270 0.0041
468 MENSTRUATION IRREGULAR 111 0.0041
469 CONFUSIONAL STATE 667 0.0041
470 EYE HAEMORRHAGE 55 0.0041
471 FUNGAL INFECTION 137 0.0041
472 THERAPEUTIC RESPONSE CHANGED 26 0.0041
473 NAUSEA 3247 0.0041
474 IMPAIRED HEALING 134 0.0041
475 ABDOMINAL PAIN UPPER 840 0.0041
476 RASH ERYTHEMATOUS 195 0.0041
477 ANOSMIA 59 0.0041
478 PULMONARY ARTERIAL HYPERTENSION 59 0.0041
479 GOUT 73 0.0041
480 VISION BLURRED 558 0.0041
481 POST PROCEDURAL COMPLICATION 78 0.0041
482 HYPERHIDROSIS 523 0.0041
483 RENAL PAIN 43 0.0041
484 HAEMORRHOIDS 79 0.0040
485 BACTERAEMIA 48 0.0040
486 APPLICATION SITE ERYTHEMA 106 0.0040
487 SKIN MASS 27 0.0040
488 HAEMATOCHEZIA 223 0.0040
489 STOMATITIS 245 0.0040
490 SENSATION OF FOREIGN BODY 34 0.0040
491 MULTIPLE SCLEROSIS RELAPSE 276 0.0040
492 THINKING ABNORMAL 75 0.0040
493 HUNGER 56 0.0040
494 JOINT SWELLING 485 0.0040
495 CATARACT 239 0.0040
496 AMNESIA 261 0.0040
497 OVARIAN CYST 40 0.0040
498 OBSESSIVE-COMPULSIVE DISORDER 32 0.0040
499 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 208 0.0040
500 RECALLED PRODUCT ADMINISTERED 38 0.0040
501 LYMPHADENOPATHY 141 0.0040
502 NEPHROLITHIASIS 182 0.0040
503 LIP SWELLING 132 0.0040
504 PULMONARY MASS 59 0.0040
505 BLOOD PRESSURE INCREASED 603 0.0039
506 SPINAL FRACTURE 79 0.0039
507 ECCHYMOSIS 27 0.0039
508 MALNUTRITION 44 0.0039
509 GLOSSODYNIA 88 0.0039
510 LUNG INFECTION 61 0.0039
511 ARTERIOSCLEROSIS CORONARY ARTERY 26 0.0039
512 KIDNEY INFECTION 77 0.0039
513 COUGH 1100 0.0039
514 INJECTION SITE DISCOLOURATION 49 0.0039
515 OSTEOMYELITIS 71 0.0039
516 RETINAL DETACHMENT 36 0.0039
517 ABDOMINAL PAIN LOWER 99 0.0039
518 BACTERIAL INFECTION 73 0.0039
519 SUBDURAL HAEMATOMA 56 0.0039
520 NASOPHARYNGITIS 721 0.0039
521 INJECTION SITE RASH 120 0.0039
522 PRODUCTIVE COUGH 186 0.0039
523 CARDIAC FAILURE CONGESTIVE 312 0.0039
524 BLOOD POTASSIUM INCREASED 63 0.0039
525 MADAROSIS 45 0.0039
526 QUALITY OF LIFE DECREASED 52 0.0039
527 BLOOD ALKALINE PHOSPHATASE INCREASED 96 0.0039
528 SENSORY LOSS 31 0.0038
529 LUNG INFILTRATION 34 0.0038
530 RHINITIS 31 0.0038
531 RASH PUSTULAR 28 0.0038
532 STENT PLACEMENT 31 0.0038
533 HALLUCINATION, VISUAL 81 0.0038
534 ANAEMIA 731 0.0038
535 VERTIGO 233 0.0038
536 SCRATCH 40 0.0038
537 ATAXIA 45 0.0038
538 ORTHOSTATIC HYPOTENSION 66 0.0038
539 ALOPECIA 744 0.0038
540 CHOLECYSTITIS 45 0.0038
541 COELIAC DISEASE 37 0.0038
542 THROAT TIGHTNESS 102 0.0038
543 JOINT EFFUSION 26 0.0038
544 DERMATITIS 79 0.0038
545 LOCALISED INFECTION 91 0.0038
546 BLOOD UREA INCREASED 63 0.0038
547 HAIR GROWTH ABNORMAL 26 0.0038
548 IRRITABILITY 223 0.0037
549 ABDOMINAL DISCOMFORT 622 0.0037
550 HERPES ZOSTER 213 0.0037
551 INJECTION SITE SWELLING 284 0.0037
552 DRY EYE 185 0.0037
553 SPEECH DISORDER 194 0.0037
554 ERYTHEMA 761 0.0037
555 ERECTILE DYSFUNCTION 95 0.0037
556 CARDIAC MURMUR 32 0.0037
557 COLITIS 140 0.0037
558 DEPRESSED MOOD 195 0.0037
559 WEIGHT INCREASED 825 0.0037
560 COGNITIVE DISORDER 172 0.0037
561 MULTIPLE SCLEROSIS 176 0.0037
562 APHASIA 111 0.0037
563 VISUAL ACUITY REDUCED 122 0.0037
564 BLOOD BILIRUBIN INCREASED 99 0.0037
565 PNEUMONIA 1176 0.0036
566 FOOD ALLERGY 28 0.0036
567 DYSPNOEA 2048 0.0036
568 BLISTER 202 0.0036
569 PSORIASIS 469 0.0036
570 PERICARDIAL EFFUSION 83 0.0036
571 BIPOLAR DISORDER 39 0.0036
572 MANIA 59 0.0036
573 GASTRIC DISORDER 123 0.0036
574 HALLUCINATION 270 0.0036
575 FIBROMYALGIA 87 0.0036
576 OEDEMA 194 0.0036
577 ASPARTATE AMINOTRANSFERASE INCREASED 190 0.0036
578 GASTROINTESTINAL INFECTION 32 0.0036
579 RENAL FAILURE 474 0.0036
580 ELECTROCARDIOGRAM ABNORMAL 28 0.0036
581 EMPHYSEMA 36 0.0036
582 POST PROCEDURAL INFECTION 29 0.0036
583 ASPIRATION 39 0.0036
584 APPLICATION SITE REACTION 25 0.0036
585 DIPLOPIA 92 0.0035
586 LIVER FUNCTION TEST ABNORMAL 103 0.0035
587 HEPATIC ENCEPHALOPATHY 33 0.0035
588 SKIN FISSURES 69 0.0035
589 BODY TEMPERATURE INCREASED 72 0.0035
590 PSORIATIC ARTHROPATHY 143 0.0035
591 MEDICAL DEVICE COMPLICATION 26 0.0035
592 MASS 49 0.0035
593 SPLENOMEGALY 41 0.0035
594 SLEEP DISORDER 247 0.0035
595 SKIN LACERATION 38 0.0035
596 SKIN HYPERPIGMENTATION 30 0.0035
597 MOVEMENT DISORDER 112 0.0035
598 SKIN DISORDER 116 0.0035
599 URINARY RETENTION 116 0.0035
600 BLINDNESS UNILATERAL 49 0.0035
601 SOMNOLENCE 699 0.0035
602 ANAL INCONTINENCE 31 0.0034
603 PRODUCT ODOUR ABNORMAL 36 0.0034
604 SECRETION DISCHARGE 43 0.0034
605 PHARMACEUTICAL PRODUCT COMPLAINT 89 0.0034
606 EYE PAIN 193 0.0034
607 DERMATITIS CONTACT 39 0.0034
608 BLOOD PRESSURE FLUCTUATION 82 0.0034
609 CARDIOMEGALY 42 0.0034
610 HERNIA 66 0.0034
611 INTERNAL HAEMORRHAGE 39 0.0034
612 GRIP STRENGTH DECREASED 30 0.0034
613 RASH 1481 0.0034
614 APPLICATION SITE PRURITUS 77 0.0034
615 SWOLLEN TONGUE 106 0.0034
616 CARDIOMYOPATHY 50 0.0034
617 CHOKING 66 0.0034
618 PLATELET COUNT DECREASED 360 0.0034
619 HAIR COLOUR CHANGES 42 0.0034
620 PRODUCT QUALITY ISSUE 458 0.0034
621 INJURY 236 0.0034
622 JOINT RANGE OF MOTION DECREASED 45 0.0034
623 HYPOTHYROIDISM 107 0.0033
624 DYSARTHRIA 126 0.0033
625 LACRIMATION INCREASED 101 0.0033
626 PROSTATIC SPECIFIC ANTIGEN INCREASED 46 0.0033
627 FOOT DEFORMITY 37 0.0033
628 PERSONALITY CHANGE 31 0.0033
629 DECREASED ACTIVITY 36 0.0033
630 INJECTION SITE REACTION 229 0.0033
631 HEPATIC ENZYME INCREASED 226 0.0033
632 ARTERIAL OCCLUSIVE DISEASE 26 0.0033
633 UTERINE PERFORATION 28 0.0033
634 HAEMOPTYSIS 92 0.0033
635 WOUND 92 0.0033
636 CENTRAL NERVOUS SYSTEM LESION 45 0.0033
637 SUICIDAL IDEATION 299 0.0033
638 DYSPHAGIA 310 0.0033
639 INFLUENZA 364 0.0033
640 IMMUNE SYSTEM DISORDER 43 0.0033
641 SKIN ULCER 84 0.0032
642 THYROID DISORDER 50 0.0032
643 URTICARIA 542 0.0032
644 WHITE BLOOD CELL COUNT INCREASED 124 0.0032
645 GAIT INABILITY 108 0.0032
646 PYELONEPHRITIS 28 0.0032
647 SKIN SWELLING 28 0.0032
648 DRUG ADMINISTRATION ERROR 99 0.0032
649 ARTHROPATHY 179 0.0032
650 GLAUCOMA 62 0.0032
651 UNRESPONSIVE TO STIMULI 83 0.0032
652 APNOEA 25 0.0032
653 INTESTINAL OBSTRUCTION 121 0.0032
654 MALIGNANT MELANOMA 43 0.0032
655 INTESTINAL PERFORATION 36 0.0032
656 THROMBOSIS 258 0.0032
657 BLOOD TEST ABNORMAL 45 0.0032
658 DEVICE DISLOCATION 139 0.0032
659 ABSCESS 51 0.0032
660 PYREXIA 1104 0.0032
661 HEMIPARESIS 54 0.0032
662 ARTERIOSCLEROSIS 30 0.0032
663 PRURITUS 1222 0.0032
664 PULMONARY OEDEMA 142 0.0032
665 SPUTUM DISCOLOURED 30 0.0032
666 HEART RATE DECREASED 111 0.0032
667 ESCHERICHIA INFECTION 26 0.0032
668 HEPATOMEGALY 31 0.0032
669 WEIGHT FLUCTUATION 33 0.0032
670 PAIN 1937 0.0032
671 EATING DISORDER 67 0.0031
672 SWELLING 293 0.0031
673 VOMITING 1471 0.0031
674 HAEMATURIA 107 0.0031
675 HYSTERECTOMY 27 0.0031
676 SEPSIS 347 0.0031
677 SKIN HAEMORRHAGE 46 0.0031
678 BLOOD GLUCOSE DECREASED 149 0.0031
679 EYE DISORDER 102 0.0031
680 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 149 0.0031
681 COMPLICATION ASSOCIATED WITH DEVICE 45 0.0031
682 HAEMODIALYSIS 26 0.0031
683 POST PROCEDURAL HAEMORRHAGE 36 0.0031
684 ACUTE KIDNEY INJURY 473 0.0031
685 INCREASED APPETITE 59 0.0031
686 COLITIS ULCERATIVE 138 0.0031
687 IRRITABLE BOWEL SYNDROME 66 0.0031
688 GINGIVAL BLEEDING 42 0.0031
689 GENERALISED OEDEMA 38 0.0031
690 SYNCOPE 307 0.0031
691 APPLICATION SITE RASH 42 0.0031
692 WITHDRAWAL SYNDROME 128 0.0030
693 INCORRECT PRODUCT STORAGE 40 0.0030
694 LEUKOCYTOSIS 55 0.0030
695 HALLUCINATION, AUDITORY 48 0.0030
696 BLOOD PRESSURE ABNORMAL 60 0.0030
697 MYOPATHY 26 0.0030
698 RESTLESSNESS 110 0.0030
699 CORONARY ARTERY DISEASE 91 0.0030
700 NEPHROPATHY 28 0.0030
701 ABNORMAL BEHAVIOUR 118 0.0030
702 HYPERSENSITIVITY 552 0.0030
703 HAEMATOMA 77 0.0030
704 AGITATION 218 0.0030
705 RENAL INJURY 88 0.0030
706 ASCITES 87 0.0030
707 TASTE DISORDER 60 0.0030
708 ULCER 47 0.0030
709 HEPATIC STEATOSIS 55 0.0029
710 NO THERAPEUTIC RESPONSE 36 0.0029
711 EYELID PTOSIS 30 0.0029
712 WHEEZING 175 0.0029
713 IMMUNOSUPPRESSION 26 0.0029
714 ALANINE AMINOTRANSFERASE INCREASED 180 0.0029
715 EUPHORIC MOOD 30 0.0029
716 DYSKINESIA 119 0.0029
717 UROSEPSIS 27 0.0029
718 SKIN CANCER 63 0.0029
719 EYELID OEDEMA 34 0.0029
720 BLOOD GLUCOSE FLUCTUATION 32 0.0029
721 BLOOD PRESSURE DECREASED 194 0.0029
722 LOWER LIMB FRACTURE 56 0.0029
723 PHARYNGITIS 36 0.0029
724 SPINAL PAIN 34 0.0029
725 CANDIDA INFECTION 49 0.0029
726 OXYGEN SATURATION DECREASED 163 0.0029
727 KNEE ARTHROPLASTY 61 0.0029
728 ROAD TRAFFIC ACCIDENT 121 0.0029
729 PSYCHOMOTOR HYPERACTIVITY 48 0.0029
730 TUBULOINTERSTITIAL NEPHRITIS 54 0.0029
731 HYPERTENSION 610 0.0029
732 HIP ARTHROPLASTY 44 0.0029
733 ADVERSE DRUG REACTION 255 0.0028
734 JOINT DISLOCATION 30 0.0028
735 OESOPHAGITIS 31 0.0028
736 BLOOD CREATININE INCREASED 185 0.0028
737 DEVICE MALFUNCTION 199 0.0028
738 WOUND INFECTION 31 0.0028
739 DEMENTIA 79 0.0028
740 MELAENA 62 0.0028
741 SINUS TACHYCARDIA 40 0.0028
742 PRODUCT TASTE ABNORMAL 38 0.0028
743 LOSS OF CONSCIOUSNESS 359 0.0028
744 HYPOMAGNESAEMIA 39 0.0028
745 AGGRESSION 140 0.0028
746 DEVICE RELATED INFECTION 43 0.0028
747 VISUAL IMPAIRMENT 346 0.0028
748 DEAFNESS 73 0.0028
749 FEMUR FRACTURE 86 0.0028
750 INTENTIONAL PRODUCT MISUSE 243 0.0028
751 DISEASE PROGRESSION 328 0.0028
752 EJECTION FRACTION DECREASED 43 0.0028
753 RESPIRATORY TRACT INFECTION 72 0.0028
754 MALAISE 1208 0.0028
755 PULMONARY THROMBOSIS 30 0.0027
756 GASTROENTERITIS 40 0.0027
757 TOOTH EXTRACTION 34 0.0027
758 EMOTIONAL DISORDER 84 0.0027
759 LIMB INJURY 74 0.0027
760 CONDITION AGGRAVATED 827 0.0027
761 RED BLOOD CELL SEDIMENTATION RATE INCREASED 30 0.0027
762 CONVULSION 155 0.0027
763 RHEUMATOID ARTHRITIS 307 0.0027
764 AFFECT LABILITY 26 0.0027
765 GASTRITIS 71 0.0027
766 SKIN REACTION 38 0.0027
767 PANCREATITIS 142 0.0027
768 PETECHIAE 28 0.0027
769 DIALYSIS 38 0.0027
770 TYPE 2 DIABETES MELLITUS 90 0.0027
771 DEVICE EXPULSION 173 0.0027
772 SKIN LESION 73 0.0027
773 MYDRIASIS 34 0.0026
774 PALLOR 72 0.0026
775 MENTAL DISORDER 115 0.0026
776 HYPOTENSION 528 0.0026
777 MUSCULOSKELETAL DISORDER 50 0.0026
778 INJECTION SITE HAEMATOMA 38 0.0026
779 FEEDING DISORDER 53 0.0026
780 SALIVARY HYPERSECRETION 26 0.0026
781 DEVICE ISSUE 233 0.0026
782 PROCEDURAL PAIN 72 0.0026
783 DISCOMFORT 158 0.0026
784 PNEUMONITIS 70 0.0026
785 OCULAR HYPERAEMIA 122 0.0026
786 EYE PRURITUS 86 0.0026
787 CARDIAC DISORDER 239 0.0026
788 BLOOD GLUCOSE INCREASED 480 0.0025
789 PANCYTOPENIA 141 0.0025
790 INFLAMMATION 130 0.0025
791 NEUTROPHIL COUNT DECREASED 102 0.0025
792 OCULAR DISCOMFORT 28 0.0025
793 HYPONATRAEMIA 140 0.0025
794 INFUSION SITE PAIN 32 0.0025
795 PNEUMONIA ASPIRATION 62 0.0025
796 ANGINA PECTORIS 71 0.0025
797 MOUTH ULCERATION 52 0.0025
798 BLOOD PRESSURE SYSTOLIC INCREASED 48 0.0025
799 TACHYCARDIA 218 0.0025
800 HAEMATEMESIS 62 0.0024
801 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 57 0.0024
802 GASTRIC HAEMORRHAGE 28 0.0024
803 RESPIRATORY FAILURE 177 0.0024
804 RENAL DISORDER 113 0.0024
805 IMPAIRED GASTRIC EMPTYING 33 0.0024
806 PANCREATITIS ACUTE 54 0.0024
807 PNEUMOTHORAX 38 0.0024
808 DRUG INEFFECTIVE 3158 0.0024
809 SEIZURE 275 0.0024
810 EYE IRRITATION 137 0.0024
811 HYPOKALAEMIA 109 0.0024
812 INJECTION SITE IRRITATION 30 0.0024
813 GASTROINTESTINAL DISORDER 211 0.0024
814 HAEMORRHAGE INTRACRANIAL 35 0.0023
815 APPLICATION SITE IRRITATION 29 0.0023
816 ELECTROLYTE IMBALANCE 27 0.0023
817 HYPOACUSIS 100 0.0023
818 HYPERKALAEMIA 81 0.0023
819 PRESCRIBED UNDERDOSE 46 0.0023
820 MEDICATION ERROR 128 0.0023
821 SEXUAL DYSFUNCTION 27 0.0023
822 DRUG DISPENSING ERROR 35 0.0023
823 LIVER FUNCTION TEST INCREASED 49 0.0023
824 COLON CANCER 34 0.0023
825 ARRHYTHMIA 108 0.0023
826 PRODUCT PHYSICAL ISSUE 46 0.0023
827 ACUTE MYOCARDIAL INFARCTION 67 0.0023
828 LYMPHOMA 35 0.0023
829 PREGNANCY 45 0.0022
830 ENCEPHALOPATHY 55 0.0022
831 DRUG PRESCRIBING ERROR 43 0.0022
832 PARALYSIS 32 0.0022
833 HEPATIC CIRRHOSIS 42 0.0022
834 CEREBRAL HAEMORRHAGE 80 0.0022
835 UNDERDOSE 163 0.0022
836 DERMATITIS ALLERGIC 28 0.0022
837 PLATELET COUNT INCREASED 29 0.0022
838 ORAL HERPES 43 0.0022
839 INFECTION 316 0.0022
840 GLYCOSYLATED HAEMOGLOBIN INCREASED 55 0.0022
841 ACCIDENT 26 0.0022
842 HYPERGLYCAEMIA 79 0.0022
843 CEREBROVASCULAR ACCIDENT 367 0.0022
844 INCORRECT DOSE ADMINISTERED 493 0.0022
845 HAEMORRHAGE 225 0.0022
846 MULTI-ORGAN FAILURE 37 0.0021
847 MULTIPLE FRACTURES 35 0.0021
848 VENTRICULAR TACHYCARDIA 35 0.0021
849 RESPIRATORY DISORDER 63 0.0021
850 CYANOSIS 33 0.0021
851 THROMBOCYTOPENIA 233 0.0021
852 JAUNDICE 56 0.0021
853 IMMUNODEFICIENCY 31 0.0021
854 HYPERTHYROIDISM 30 0.0021
855 OBESITY 33 0.0021
856 PSYCHOTIC DISORDER 61 0.0021
857 GENERALISED TONIC-CLONIC SEIZURE 34 0.0021
858 AMENORRHOEA 36 0.0021
859 SEPTIC SHOCK 89 0.0020
860 DEVICE FAILURE 31 0.0020
861 EXTRA DOSE ADMINISTERED 82 0.0020
862 LUNG DISORDER 98 0.0020
863 CONJUNCTIVITIS 37 0.0020
864 METASTASES TO LIVER 35 0.0020
865 ECONOMIC PROBLEM 30 0.0020
866 LIVER DISORDER 87 0.0020
867 EXPIRED PRODUCT ADMINISTERED 65 0.0020
868 ASTHMA 221 0.0020
869 SEDATION 51 0.0019
870 ANHEDONIA 51 0.0019
871 BONE LOSS 29 0.0019
872 PULMONARY FIBROSIS 37 0.0019
873 ACUTE MYELOID LEUKAEMIA 30 0.0019
874 INTENTIONAL DRUG MISUSE 40 0.0019
875 TACHYPNOEA 26 0.0019
876 DELIRIUM 66 0.0019
877 MYOCARDIAL INFARCTION 331 0.0019
878 PRODUCT USE ISSUE 356 0.0019
879 BRONCHOSPASM 27 0.0019
880 ADVERSE REACTION 25 0.0019
881 RESPIRATORY DISTRESS 52 0.0019
882 SEROTONIN SYNDROME 36 0.0019
883 BRADYCARDIA 99 0.0019
884 PRESCRIBED OVERDOSE 36 0.0019
885 HYPOGLYCAEMIA 90 0.0019
886 HOSPITALISATION 283 0.0018
887 FEBRILE NEUTROPENIA 121 0.0018
888 BONE DENSITY DECREASED 57 0.0018
889 NEUTROPENIA 247 0.0018
890 SURGERY 106 0.0018
891 STEVENS-JOHNSON SYNDROME 40 0.0018
892 DIABETES MELLITUS 136 0.0018
893 FACE OEDEMA 30 0.0018
894 THERAPY INTERRUPTED 127 0.0018
895 DEPRESSED LEVEL OF CONSCIOUSNESS 70 0.0018
896 DRUG INTERACTION 280 0.0018
897 RENAL IMPAIRMENT 148 0.0018
898 LYMPHOCYTE COUNT DECREASED 31 0.0018
899 INTENTIONAL PRODUCT USE ISSUE 153 0.0017
900 PERICARDITIS 29 0.0017
901 ABORTION SPONTANEOUS 69 0.0017
902 TOOTH LOSS 35 0.0017
903 BLOOD GLUCOSE ABNORMAL 31 0.0017
904 INJURY ASSOCIATED WITH DEVICE 34 0.0017
905 METABOLIC ACIDOSIS 53 0.0017
906 PRODUCT USE COMPLAINT 26 0.0016
907 MALIGNANT NEOPLASM PROGRESSION 169 0.0016
908 METASTASES TO BONE 27 0.0016
909 TREATMENT NONCOMPLIANCE 90 0.0016
910 INCORRECT ROUTE OF DRUG ADMINISTRATION 58 0.0016
911 THERAPY NON-RESPONDER 72 0.0016
912 ILL-DEFINED DISORDER 97 0.0016
913 DIABETES MELLITUS INADEQUATE CONTROL 28 0.0016
914 RASH MACULO-PAPULAR 35 0.0016
915 DRUG LEVEL INCREASED 26 0.0016
916 NERVOUS SYSTEM DISORDER 49 0.0016
917 MUCOSAL INFLAMMATION 41 0.0016
918 BLOOD CREATINE PHOSPHOKINASE INCREASED 45 0.0016
919 CARDIO-RESPIRATORY ARREST 65 0.0016
920 DRUG INTOLERANCE 150 0.0016
921 DRUG WITHDRAWAL SYNDROME 136 0.0015
922 NEEDLE ISSUE 45 0.0015
923 TRANSAMINASES INCREASED 34 0.0015
924 CARDIAC ARREST 124 0.0015
925 PERITONITIS 31 0.0015
926 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 81 0.0015
927 THERAPEUTIC RESPONSE DECREASED 89 0.0015
928 CARDIAC FAILURE 117 0.0015
929 DIABETIC KETOACIDOSIS 35 0.0015
930 GENERAL PHYSICAL HEALTH DETERIORATION 168 0.0015
931 INCORRECT DOSE ADMINISTERED BY DEVICE 38 0.0014
932 HEPATITIS 37 0.0014
933 PRODUCT ADHESION ISSUE 50 0.0014
934 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 47 0.0014
935 ELECTROCARDIOGRAM QT PROLONGED 50 0.0014
936 HEPATIC FAILURE 41 0.0014
937 ADVERSE EVENT 125 0.0014
938 DRUG EXPOSURE DURING PREGNANCY 46 0.0014
939 LUNG NEOPLASM MALIGNANT 55 0.0013
940 ANAPHYLACTIC REACTION 73 0.0013
941 EMOTIONAL DISTRESS 158 0.0013
942 OFF LABEL USE 1141 0.0013
943 LEUKOPENIA 65 0.0013
944 ECZEMA 67 0.0013
945 LOWER RESPIRATORY TRACT INFECTION 58 0.0013
946 OSTEONECROSIS OF JAW 31 0.0013
947 BLINDNESS 51 0.0013
948 SYSTEMIC LUPUS ERYTHEMATOSUS 44 0.0012
949 ACCIDENTAL OVERDOSE 45 0.0012
950 ANGIOEDEMA 54 0.0012
951 INFUSION RELATED REACTION 80 0.0012
952 BREAST CANCER 112 0.0012
953 DISEASE RECURRENCE 57 0.0012
954 EXPOSURE DURING PREGNANCY 74 0.0012
955 CEREBRAL INFARCTION 29 0.0012
956 RESPIRATORY ARREST 32 0.0012
957 C-REACTIVE PROTEIN INCREASED 42 0.0012
958 DEATH 989 0.0011
959 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 230 0.0011
960 RHABDOMYOLYSIS 47 0.0011
961 TARDIVE DYSKINESIA 31 0.0011
962 OSTEONECROSIS 36 0.0011
963 INTENTIONAL DOSE OMISSION 31 0.0011
964 COMA 50 0.0010
965 LACTIC ACIDOSIS 34 0.0010
966 OVERDOSE 222 0.0010
967 PRODUCT COMPLAINT 26 0.0010
968 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 184 0.0010
969 THERAPEUTIC RESPONSE SHORTENED 33 0.0010
970 NEOPLASM MALIGNANT 65 0.0010
971 DEVICE LEAKAGE 42 0.0010
972 DEVICE BREAKAGE 39 0.0010
973 PANCREATIC CARCINOMA 27 0.0009
974 INTERSTITIAL LUNG DISEASE 45 0.0009
975 NEOPLASM PROGRESSION 31 0.0009
976 THERAPEUTIC PRODUCT EFFECT DECREASED 38 0.0008
977 PROSTATE CANCER 68 0.0008
978 PRODUCT USE IN UNAPPROVED INDICATION 180 0.0007
979 TOXICITY TO VARIOUS AGENTS 118 0.0007
980 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 32 0.0007
981 SUICIDE ATTEMPT 35 0.0006
982 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 40 0.0006
983 DEVICE DIFFICULT TO USE 33 0.0005
984 PRODUCT DOSE OMISSION ISSUE 144 0.0005
985 COVID-19 83 0.0005
986 TREATMENT FAILURE 38 0.0005
987 ACCIDENTAL EXPOSURE TO PRODUCT 41 0.0004
988 MATERNAL EXPOSURE DURING PREGNANCY 35 0.0004
989 NO ADVERSE EVENT 63 0.0003
990 ILLNESS 32 0.0003
991 DRUG DEPENDENCE 47 0.0003